Alkaloid-Non-Alkaloid Composition for Synergistic Bioavailability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing therapeutic compounds often require multifunctional and multifaceted impacts to achieve the desired physiological response due to complex cellular pathways and dynamic cellular states, necessitating compositions of multiple molecules over single compounds for enhanced therapeutic effects.
Innovation Solution
A composition comprising a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components, formulated to be administered orally, with specific components selected based on biological impact and enhanced by additional natural, synthetically manufactured, or bioequivalent components to increase bioavailability and synergistic therapeutic results.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single compounds are used for therapy, then the treatment is simple and easy to administer, but the therapeutic effect is insufficient due to complex cellular pathways requiring multifunctional impact
Solution Approach 1:
The patent combines multiple biologically active compounds into a single pharmaceutical composition. Specifically, it merges at least one alkaloid compound with at least one non-alkaloid compound in defined weight ratios (e.g., 1:4 to 4:1) to create a synergistic formulation that addresses complex cellular pathways through multifunctional action, thereby resolving the contradiction between therapeutic efficacy and composition simplicity.
Solution Approach 2:
The invention creates a composite pharmaceutical composition consisting of different types of compounds (alkaloids and non-alkaloids) with complementary biological activities. This composite approach allows the formulation to target multiple cellular pathways simultaneously, achieving reliable therapeutic effects while maintaining a manageable composition structure through defined ratios and preparation methods.
2Reliability
If plant extracts are consolidated to achieve effective concentration, then the therapeutic potential is enhanced, but the quantity required becomes impractical to achieve through consumption of the total plant
Solution Approach 1:
The patent extracts and isolates specific biologically active compounds (alkaloids and non-alkaloids) from plant sources, separating the therapeutically effective components from the bulk plant material. This extraction process concentrates the active ingredients into a manageable formulation, allowing effective therapeutic concentrations to be achieved without requiring impractical quantities of whole plant consumption.
Solution Approach 2:
The invention changes the concentration parameter of active compounds by extracting and purifying them from plant sources. The formulation contains highly concentrated amounts of specific alkaloid and non-alkaloid compounds in defined weight ratios, transforming the low-concentration state of whole plant extracts into a high-concentration pharmaceutical preparation that achieves therapeutic efficacy in practical dosages.
3Reliability
If multiple molecules are combined to achieve synergistic therapeutic results, then the therapeutic effect is enhanced, but the manufacturing and formulation process becomes more complex
Solution Approach 1:
The patent simplifies the manufacturing process by defining specific weight ratio parameters for combining alkaloid and non-alkaloid compounds (e.g., 1:4 to 4:1 ratios). These parameter specifications provide clear manufacturing guidelines that balance synergistic therapeutic effects with ease of production, allowing complex multi-compound formulations to be manufactured systematically rather than through trial-and-error approaches.
Data Source
AI summary
A composition comprising a therapeutically effective amount of at least one alkaloid combined with one or more non-alkaloid components, wherein the composition is configured to be administered to a subject.